Universal-Beteiligungs- und Servicegesellschaft’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.7M Sell
88,635
-26,944
-23% -$15.1M 0.07% 237
2026
Q1
$64.9M Buy
115,579
+1,425
+1% +$914K 0.11% 167
2025
Q4
$77.4M Buy
114,154
+909
+0.8% +$619K 0.13% 152
2025
Q3
$72.4M Sell
113,245
-60,082
-35% -$36.5M 0.12% 156
2025
Q2
$93M Buy
173,327
+23,029
+15% +$11M 0.16% 126
2025
Q1
$63.1M Buy
150,298
+56,408
+60% +$24.5M 0.13% 162
2024
Q4
$38.8M Buy
+93,890
New +$41.2M 0.08% 236

Other funds holding IDXX

Universal-Beteiligungs- und Servicegesellschaft's IDXX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Idexx Laboratories (IDXX) stake by 23% in Q2 2026, selling an estimated $15.1M and leaving 88,635 shares worth $46.7M. The position accounts for 0.07% of the portfolio, ranked #237.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $93M in Q2 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 88,635 shares of Idexx Laboratories worth $46.7M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 26,944 Idexx Laboratories shares in Q2 2026, an estimated $15.1M.
  • Idexx Laboratories made up 0.07% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #237 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Idexx Laboratories position peaked at $93M in Q2 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.